Literature DB >> 9504955

Skeletal response to dietary zinc in adult female mice.

H P Dimai1, S L Hall, B Stilt-Coffing, J R Farley.   

Abstract

The current studies were intended to assess dose- and time-dependent effects of dietary zinc (Zn) on alkaline phosphatase (ALP) activity and tartrate-resistant acid phosphatase (TRAP) activity in adult female mice. In the first study, mice were given 0, 1x, 2x, 3x, or 4x normal dietary Zn for 2 weeks, 4 weeks, or 6 weeks. In the second study, mice were given 0, 1x, 2x, 3x, 4x, and 5x normal dietary Zn for 4 weeks. Sera were collected for measurements of ALP and (in the second study) osteocalcin. Tibiae and calvaria were extracted for measurements of ALP, protein, and TRAP. The first study showed positive correlations between dietary Zn and serum ALP (4 and 6 weeks, P < 0.001), Zn and tibial ALP (2, 4, and 6 weeks, P < 0.03), and Zn and tibial protein (2, 4, and 6 weeks, P < 0.001), as well as a negative correlation between dietary Zn and tibial TRAP (2, 4, and 6 weeks, P < 0.001). Covariant analyses showed that serum ALP, tibial ALP, tibial protein, and tibial TRAP were affected by the dose of Zn (P < 0.005) and by the treatment time (P < 0.03). Supplemental studies showed that (1) the dose-dependent effect of dietary Zn on serum ALP (at 6 weeks) was proportional to the effects on tibial ALP and calvarial ALP, but not to the effects of Zn on renal, hepatic, or intestinal ALP; (2) 6 weeks of dietary Zn caused dose-dependent increases in ALP specific activity in the tibia, calvaria, and liver, but not kidneys or intestines; and (3) Zn increased ALP activity and cell layer protein and decreased TRAP activity in monolayer cultures of the murine osteoblastic cell line, MC3T3-E1. The second dietary study confirmed the results of the first: 4 weeks of treatment with Zn caused significant increases in serum ALP, calvarial ALP, and tibial ALP activities, and a significant decrease in tibial TRAP (P < 0.05-0.005 for each). This study also revealed an effect of Zn to increase serum osteocalcin (P < 0.03 at 2x normal Zn). Together, these data indicate that incremental increases in dietary Zn are associated with increases in ALP activity in serum and in bone. The effect of Zn to decrease TRAP activity in osteoblast-line cells precludes the interpretation of a Zn-dependent decrease in tibial TRAP activity as evidence of decreased bone resorption.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504955     DOI: 10.1007/s002239900437

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  4 in total

1.  Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.

Authors:  Masayoshi Yamaguchi; M Neale Weitzmann
Journal:  Mol Cell Biochem       Date:  2011-05-01       Impact factor: 3.396

Review 2.  Zinc as a Therapeutic Agent in Bone Regeneration.

Authors:  J Patrick O'Connor; Deboleena Kanjilal; Marc Teitelbaum; Sheldon S Lin; Jessica A Cottrell
Journal:  Materials (Basel)       Date:  2020-05-12       Impact factor: 3.623

3.  Zinc inhibits osteoclast differentiation by suppression of Ca2+-Calcineurin-NFATc1 signaling pathway.

Authors:  Kwang Hwan Park; Boryung Park; Dong Suk Yoon; Seung-Hyun Kwon; Dong Min Shin; Jin Woo Lee; Hyun Gyu Lee; Jae-Hyuck Shim; Jeon Han Park; Jae Myun Lee
Journal:  Cell Commun Signal       Date:  2013-10-02       Impact factor: 5.712

4.  Bioavailability of zinc in Wistar rats fed with rice fortified with zinc oxide.

Authors:  Ceres Mattos Della Lucia; Laura Luiza Menezes Santos; Kellen Cristina da Cruz Rodrigues; Vivian Cristina da Cruz Rodrigues; Hércia Stampini Duarte Martino; Helena Maria Pinheiro Sant'Ana
Journal:  Nutrients       Date:  2014-06-13       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.